NCT03787589 Exercise in Patients With End Stage Kidney Disease
| NCT ID | NCT03787589 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ottawa Hospital Research Institute |
| Condition | Renal Failure |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2019-04-15 |
| Primary Completion | 2025-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2019-04-15 with a primary completion date of 2025-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will be conducted over a 3 year time period. This is a trial of an exercise intervention vs. standard of care in patients receiving chronic dialysis. The specific aims will be to determine feasibility of patient recruitment, adherence to the exercise program, and efficacy of the intervention on patient important outcomes. The exercise intervention will be delivered to randomized participants for 12 months, and consist of the prescribed use of Nordic Walking poles, online resources for exercise in the home, regular use of a pedometer to monitor progress, and regular verbal encouragement to exercise (monthly) by dialysis unit staff. Both groups will receive the same standard of care co-interventions including individualized dialysis prescriptions and health-care interactions according to practices at their centre.
Eligibility Criteria
Inclusion Criteria: 1. All ambulatory adult patients with end stage kidney disease 2. Treatment with peritoneal dialysis or hemodialysis for greater than six months 3. Able to understand English or French 4. Abuse to use Nordic Walking poles 5. Able and willing to provide informed consent Exclusion Criteria: 1. Any absolute contraindication to exercise \[unstable angina, uncontrolled hypertension (systolic or diastolic blood pressure greater than 180 mmHg (millimeters of mercury) or greater than 110 mmHg, respectively), deemed not suitable for exercise by the treating physician\] 2. Baseline step count greater than 8000 steps a day 3. Planned living donor kidney transplant 4. Potential for recovery of renal function 5. Patients who feel unsafe using Nordic walking poles in place of their mobility aid 6. Participation in another interventional trial that may affect the results of this study
Contact & Investigator
Deborah Zimmerman, MD, MSc
PRINCIPAL INVESTIGATOR
Ottawa Hospital Research Institute
Frequently Asked Questions
Who can join the NCT03787589 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Renal Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03787589 currently recruiting?
Yes, NCT03787589 is actively recruiting participants. Contact the research team at dzimmerman@toh.ca for enrollment information.
Where is the NCT03787589 trial being conducted?
This trial is being conducted at Ottawa, Canada.
Who is sponsoring the NCT03787589 clinical trial?
NCT03787589 is sponsored by Ottawa Hospital Research Institute. The principal investigator is Deborah Zimmerman, MD, MSc at Ottawa Hospital Research Institute. The trial plans to enroll 90 participants.